These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11710695

  • 1. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
    Zhao D, Ogawa H, Wang X, Cameron GS, Baty DE, Dlott JS, Triplett DA.
    Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
    [Abstract] [Full Text] [Related]

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 3. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [Abstract] [Full Text] [Related]

  • 4. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
    Bećarevic M, Andrejević S, Bonaci-Nikolić B, Obradović I, Miljić P, Majkić-Singh N.
    Clin Lab; 2005 Mar; 51(5-6):279-83. PubMed ID: 15991801
    [Abstract] [Full Text] [Related]

  • 5. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [Abstract] [Full Text] [Related]

  • 6. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
    de Souza AW, Silva NP, de Carvalho JF, D'Almeida V, Noguti MA, Sato EI.
    Lupus; 2007 Jul; 16(10):782-7. PubMed ID: 17895300
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
    Sherer Y, Gerli R, Vaudo G, Schillaci G, Gilburd B, Giordano A, Bocci EB, Allegrucci R, Marchesi S, Mannarino E, Shoenfeld Y.
    Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
    [Abstract] [Full Text] [Related]

  • 8. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR, Matsuura E, Batuca JR, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Alves JD.
    Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI, Atsumi T, Tinahones FJ, Gómez-Zumaquero JM, Amengual O, Khamashta MA, Hughes GR.
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [Abstract] [Full Text] [Related]

  • 10. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC.
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008 Aug; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 12. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.
    Cojocaru IM, Cojocaru M, Burcin C.
    Rom J Intern Med; 2006 Aug; 44(2):165-70. PubMed ID: 17236297
    [Abstract] [Full Text] [Related]

  • 13. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA.
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [Abstract] [Full Text] [Related]

  • 14. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 15. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Kumar S, Isenberg DA.
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [Abstract] [Full Text] [Related]

  • 16. Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease?
    Ames PR, Antinolfi I, Ciampa A, Batuca J, Scenna G, Lopez LR, Delgado Alves J, Iannaccone L, Matsuura E.
    Rheumatology (Oxford); 2008 Dec; 47(12):1832-7. PubMed ID: 18930964
    [Abstract] [Full Text] [Related]

  • 17. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome.
    Becarevic M, Singh S, Majkic-Singh N.
    Clin Lab; 2008 Dec; 54(3-4):97-101. PubMed ID: 18630740
    [Abstract] [Full Text] [Related]

  • 18. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P.
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [Abstract] [Full Text] [Related]

  • 19. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.
    Freire de Carvalho J, Sherer Y, Shoenfeld Y.
    Thromb Haemost; 2007 Dec; 98(6):1157-9. PubMed ID: 18064307
    [Abstract] [Full Text] [Related]

  • 20. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.